Asabys Partners

AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.

Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies.

Cara by HiDoc Technologies is a Berlin-based pharmaceutical company established in 2015 that focuses on empowering patients with chronic digestive diseases. The company develops digital therapeutics aimed at enhancing existing therapies for gastrointestinal disorders. Cara's primary offering is a virtual health advising application that allows users to maintain a personal food and symptom diary. This application enables patients to track their dietary choices and record symptoms such as pain and bloating, helping them identify patterns related to their health. By providing tools for self-monitoring and understanding their conditions, Cara seeks to facilitate better health management for individuals suffering from digestive issues.

SidekickHealth is a digital therapeutics company focused on preventing and managing chronic diseases. It leverages behavioral economics, gamification, and artificial intelligence to create engaging experiences that facilitate behavior change and enhance health and well-being. The company collaborates with pharmaceutical companies and other organizations to develop personalized lifestyle change programs aimed at improving health outcomes and treatment adherence. Additionally, SidekickHealth connects clinical experts with patient communities and provides data insights to address significant health challenges. Its lifestyle companion app serves as a tool to support individuals on their health journeys.

Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations of adeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.

Inbrain Neuroelectronics is a medical device company based in Barcelona, Spain, founded in 2019. The company focuses on developing and commercializing innovative graphene neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. By utilizing graphene technology, Inbrain creates high-density, full implantable platforms that can decode and modulate brain activity with precision. These advanced neural systems are designed to detect specific biomarkers related to therapies and to trigger targeted adaptive responses, thereby optimizing therapeutic outcomes for patients. Inbrain Neuroelectronics is dedicated to advancing the fields of neuro and bioelectronics through its cutting-edge solutions.

Medlumics S.L. designs and manufactures catheter based systems for the treatment of supra ventricular tachycardias. The company develops integrated photonic devices using optical coherence tomography technology, a light based diagnostic technique to provide sectional information about tissue. Medlumics S.L. was founded in 2009 and is based in Tres Cantos, Spain.

Koa Health B.V. is a company founded in 2018, headquartered in Amsterdam, with additional offices in Barcelona, the United States, and the United Kingdom. The company specializes in developing digital wellbeing and therapeutic solutions that focus on mental health support for employees. Koa Health's flagship application, koa foundation, provides organizations with tools to enhance their employees' mental well-being. The company integrates the latest clinical research with innovative technologies to offer accessible, personalized, and effective mental health resources. These resources encompass prevention, prediction, and treatment, addressing a wide range of mental health conditions.

SidekickHealth is a digital therapeutics company focused on preventing and managing chronic diseases. It leverages behavioral economics, gamification, and artificial intelligence to create engaging experiences that facilitate behavior change and enhance health and well-being. The company collaborates with pharmaceutical companies and other organizations to develop personalized lifestyle change programs aimed at improving health outcomes and treatment adherence. Additionally, SidekickHealth connects clinical experts with patient communities and provides data insights to address significant health challenges. Its lifestyle companion app serves as a tool to support individuals on their health journeys.

Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations of adeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.

Origo Biopharma S.L. is a biotechnology company based in San Cibrao das Viñas, Spain, founded in 2017. The company focuses on the research and development of immunotherapeutic products aimed at treating severe diseases associated with TGF-β signaling dysfunction, specifically in gastrointestinal and lung indications. Origo Biopharma develops organ-restricted drugs that target unmet medical needs related to cancer and fibrosis, striving to provide effective treatments for these challenging health disorders.

Ona Therapeutics, S.L. is a biotechnology company based in Barcelona, Spain, founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren. As a spin-off from the ICREA and Advanced Studies and the IRB Institute for Research in Biomedicine, Ona Therapeutics focuses on the discovery and development of therapeutic biologics that target tumor metastatic-initiating cells and lipid metabolism. The company's innovative therapies aim to block pathways related to fat metabolism in animal models of cancer and inhibit the cells responsible for metastasis. This approach has the potential to prevent the development of malignant tumors and eliminate existing ones, offering new treatment options for various metastatic cancers, including those affecting the oral cavity, breast, ovaries, stomach, bladder, prostate, and melanoma.

Inbrain Neuroelectronics is a medical device company based in Barcelona, Spain, founded in 2019. The company focuses on developing and commercializing innovative graphene neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. By utilizing graphene technology, Inbrain creates high-density, full implantable platforms that can decode and modulate brain activity with precision. These advanced neural systems are designed to detect specific biomarkers related to therapies and to trigger targeted adaptive responses, thereby optimizing therapeutic outcomes for patients. Inbrain Neuroelectronics is dedicated to advancing the fields of neuro and bioelectronics through its cutting-edge solutions.

Anaconda Biomed, founded in 2015 and based in Barcelona, Spain, is an innovative medical technology company focused on developing advanced healthcare devices for the treatment of acute ischemic stroke (AIS). The company specializes in neuro-thrombectomy systems, notably the ANCD BRAIN™, a third-generation stented aspiration thrombectomy system. This system is designed to perform mechanical thrombectomies using a combination of a delivery catheter, a funnel-shaped aspiration catheter, and a stent retriever. When deployed, the stent retriever expands to conform to the artery, effectively halting blood flow and enabling the complete extraction of thrombus without fragmentation. This technology aims to provide immediate treatment for stroke patients, significantly reducing the risk of fatality.

Cara by HiDoc Technologies is a Berlin-based pharmaceutical company established in 2015 that focuses on empowering patients with chronic digestive diseases. The company develops digital therapeutics aimed at enhancing existing therapies for gastrointestinal disorders. Cara's primary offering is a virtual health advising application that allows users to maintain a personal food and symptom diary. This application enables patients to track their dietary choices and record symptoms such as pain and bloating, helping them identify patterns related to their health. By providing tools for self-monitoring and understanding their conditions, Cara seeks to facilitate better health management for individuals suffering from digestive issues.

Ona Therapeutics, S.L. is a biotechnology company based in Barcelona, Spain, founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren. As a spin-off from the ICREA and Advanced Studies and the IRB Institute for Research in Biomedicine, Ona Therapeutics focuses on the discovery and development of therapeutic biologics that target tumor metastatic-initiating cells and lipid metabolism. The company's innovative therapies aim to block pathways related to fat metabolism in animal models of cancer and inhibit the cells responsible for metastasis. This approach has the potential to prevent the development of malignant tumors and eliminate existing ones, offering new treatment options for various metastatic cancers, including those affecting the oral cavity, breast, ovaries, stomach, bladder, prostate, and melanoma.

Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies.

Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies.